Suprava Shah

I am a researcher in the field of pharmaceutical and analytical chemistry, with a strong focus on the development of innovative nanomaterials and bioactive small molecules for cancer detection and therapy. My work bridges chemistry, nanotechnology, and molecular biology, aiming to understand disease mechanisms at the molecular level and translate that knowledge into impactful diagnostic and therapeutic tools. 

My research spans several interdisciplinary domains, combining core chemical sciences with translational biomedical applications:

• Analytical Chemistry
  Developing sensitive, selective techniques for biomolecular detection and characterization.

• Early Cancer Detection
  Designing nanomaterial-based platforms for minimally invasive, high-accuracy detection of cancer biomarkers.

• Drug Discovery
  Exploring natural and synthetic small molecules—such as flavonoids—for anticancer activity, supported by structure–activity relationship (SAR) studies.

• Nanorods and Nanoparticles
  Engineering magnetic–plasmonic nanoparticles (e.g., gold nanorods, core–shell structures) for multimodal imaging, targeted drug delivery, and photothermal therapy.